publication venue for
- Impact of Long-Acting Injectable Versus Oral Antipsychotic Treatment on All-Cause Discontinuation Risk in People with Early Phase Schizophrenia and Comorbid Substance Use Disorder: A Secondary Analysis of the EULAST Randomized Trial. 2025
- Improvements in Cognitive Processing Speed, Disability, and Patient-Reported Outcomes in Patients with Early Relapsing-Remitting Multiple Sclerosis Treated with Natalizumab: Results of a 4-year, Real-World, Open-Label Study. 2022
- Psychopharmacological treatment of neurocognitive deficits in people with schizophrenia: a review of old and new targets. 2014
- Investigational Gene Therapies for Parkinson's Disease. 2025
- Unmet Needs in Psychodermatology: A Narrative Review. 2024
- Leveraging Molecular and Immune-Based Therapies in Leptomeningeal Metastases. 2022
- The pipeline in headache therapy. 2013
- Long-acting injectable formulations of new-generation antipsychotics: a review from a clinical perspective. 2013